Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dar Al Dawa Dev And Invest CofiledCriticalDar Al Dawa Dev And Invest Co
Priority to TNP2006000335ApriorityCriticalpatent/TNSN06335A1/en
Publication of TNSN06335A1publicationCriticalpatent/TNSN06335A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
THE PRESENT INVENTION RELATES IN GENERAL TO THE FIELD OF PHARMACEUTICAL COMPOSITIONS, NAMELY A PHARMACEUTICAL COMPOSITION IN THE FORM OF A SOLUTION COMPRISING THE ACTIVE INGREDIENTS RISPERIDONE. MORE PRECISELY THE PRESENT INVENTION RELATES TO A SOLUTION ORAL DOSAGE FORM COMPRISING RISPERIDONE OR A PHARMACEUTICALLY ACCEPTABLE FREE RISPERIDONE BASE OR ACID ADDITION SALT OF RESPERIDONE.
Pharmaceutical composition comprising acyclovir and a delivery agent, a dosage unit, use of acyclovir in the preparation of the pharmaceutical composition, use of the pharmaceutical composition in the preparation of a medicament and a method of preparing the pharmaceutical composition